Voyager Therapeutics Inc Asset Turnover Ratio (VYGR), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Voyager Therapeutics Inc   (NASDAQ: VYGR)
 

Voyager Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Voyager Therapeutics Inc asset turnover ratio, the ability of Voyager Therapeutics Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.13 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as VYGR's position remain challenging.

Within sector 42 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 0 to 3036.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VYGR Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -38.56 % -37.91 % -28.83 % -25.82 % 27.05 %
Y / Y Revenue Change -39.13 % -59.94 % 144.28 % -45.73 % -82.42 %
Asset Turnover Ratio (TTM) 0.13 0.11 0.11 0.08 0.11
VYGR's Total Ranking # 3036 # 0 # 0 # 1262 #
Seq. Asset Change 41.6 % -14.83 % -10.68 % -42.96 % 43.09 %
Seq. Revenue Change 22.06 % -83.09 % 14.75 % 157.02 % -19.67 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 450
Overall Market # 3036

Asset Turnover Ratio Statistics
High Average Low
0.88 0.28 0
(Mar 31 2023)   (Dec 31 2018)




VYGR Company Profile • Back to VYGR Efficiency Comparisons • Compare VYGR Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Profound Medical Corp   0.30 $ 19.086  Millions$ 63.905  Millions
Prestige Consumer Healthcare Inc   0.30 $ 1,104.957  Millions$ 3,726.846  Millions
Orchestra Biomed Holdings Inc   0.29 $ 31.976  Millions$ 109.006  Millions
Utah Medical Products Inc  0.29 $ 35.679  Millions$ 123.368  Millions
Immunitybio inc   0.29 $ 165.792  Millions$ 574.007  Millions
Zomedica Corp   0.29 $ 35.903  Millions$ 124.406  Millions
Amarin Corp Plcuk  0.29 $ 186.480  Millions$ 650.179  Millions
Orasure Technologies Inc  0.29 $ 111.978  Millions$ 391.497  Millions
Vir Biotechnology Inc   0.28 $ 303.227  Millions$ 1,065.667  Millions
Maravai Lifesciences Holdings Inc   0.28 $ 207.886  Millions$ 734.183  Millions
Atara Biotherapeutics Inc   0.28 $ 6.452  Millions$ 22.856  Millions
Assembly Biosciences Inc   0.28 $ 74.845  Millions$ 265.982  Millions
Hyperfine Inc   0.28 $ 15.425  Millions$ 55.028  Millions
Fortress Biotech Inc   0.27 $ 69.983  Millions$ 260.136  Millions
Adc Therapeutics Sa  0.27 $ 79.584  Millions$ 295.946  Millions
Repligen Corp  0.27 $ 785.101  Millions$ 2,938.591  Millions
Invivyd Inc   0.27 $ 58.365  Millions$ 219.167  Millions
Nuvation Bio Inc   0.27 $ 169.551  Millions$ 637.782  Millions
Humacyte Inc   0.26 $ 30.074  Millions$ 114.130  Millions
Hcw Biologics Inc   0.26 $ 6.843  Millions$ 26.019  Millions
Bio rad Laboratories Inc   0.26 $ 2,589.000  Millions$ 10,078.725  Millions
Innoviva Inc   0.25 $ 420.630  Millions$ 1,650.896  Millions
Siga Technologies Inc  0.25 $ 53.659  Millions$ 211.549  Millions
Biolife Solutions Inc   0.25 $ 102.718  Millions$ 411.591  Millions
Plus Therapeutics Inc   0.24 $ 4.203  Millions$ 17.235  Millions
Cryoport inc   0.24 $ 186.452  Millions$ 764.783  Millions
Editas Medicine Inc   0.24 $ 47.005  Millions$ 193.747  Millions
Revvity Inc  0.24 $ 2,911.811  Millions$ 12,087.447  Millions
Elutia Inc   0.24 $ 11.353  Millions$ 47.654  Millions
Retractable Technologies Inc  0.24 $ 33.488  Millions$ 142.089  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.